Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: Involvement of p53 accumulation via ARF-mediated MDM2 down-regulation

Clinical Cancer Research

Volumn 6, Issue 7, 2000, Pages 2851-2859

  Itoshima, Takahiro ^a   Fujiwara, Toshiyoshi ^b   Waku, Toshihiko ^b   Shao, Jianghua ^b   Kataoka, Masafumi ^b   Yarbrough, Wendell G ^c   Liu, Ta Jen ^d   Roth, Jack A ^e   Tanaka, Noriaki ^b   Kodama, Masashi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN MDM2; PROTEIN P53; TRANSCRIPTION FACTOR E2F; VIRUS VECTOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; ESOPHAGUS CANCER; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADENOVIRIDAE; APOPTOSIS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL DIVISION; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; ESOPHAGEAL NEOPLASMS; GENES, P53; GENETIC VECTORS; HUMANS; KINETICS; PROTEINS; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033927808     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kovesdi, I., Reichel, R., and Nevins, J. R. Identification of a cellular transcriptional factor involved in E1A trans-activation. Cell, 45: 219-228, 1986.
2. Sherr, C. J. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
3. Johnson, D. G., Schwarz, J. K., Cress, W. D., and Nevins, J. R. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature (Lond.), 365: 349-352, 1993.
4. Qin, X-Q., Livingston, D. M., Kaelin, W. G., and Adams, P. D. Deregulated transcriptional factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA, 91: 10918-10922, 1994.
5. Singh, P., Wong, S. W., and Hong, W. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J., 13: 3329-3338, 1994.
6. Johnson, D. G., Cress, W. D., Jakoi, L., and Nevins, J. R. Oncogenic capacity of the E2F1 gene. Proc. Natl. Acad. Sci. USA, 91: 12823-12827, 1994.
7. Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E., and Dyson, N. J. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell, 85: 537-548, 1996.
8. Wu, X., and Levine, A. J. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA, 91: 3602-3606, 1994.
9. Fueyo, J., Gomez-Manzano, C., Yung, W. K. A., Liu, T. J., Alemany, R., McDonell, T. J., Shi, X., Rao, J. S., Levin, V. A., and Kyritsis, A. P. Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo. Nat. Med., 4: 685-690, 1998.
10. Fujiwara, T., Grimm E. A., Mukhopadhyay, T., Zhang, W-W., Owen-Schaub, L. B., and Roth, J. A. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res., 54: 2287-2291, 1994.
11. 1 arrest and induces apoptosis in human cancer cells. Oncogene, 15: 1903-1910, 1997.
12. Ogawa, N., Fujiwara, T., Kagawa, S., Nishizaki, M., Morimoto, Y., Tanida, T., Hizuta, A., Yasuda, T., Roth, J. A., and Tanaka, N. Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent. Int. J. Cancer, 73: 367-360, 1997.
13. Fukazawa, T., Fujiwara, T., Morimoto, Y., Shao, J., Nishizaki, M., Kadowaki, Y., Hizuta, A., Owen-Schaub, L. B., Roth, J. A., and Tanaka, N. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells. Oncogene, 18: 2189-2199, 1999.
14. Nishizaki, M., Fujiwara, T., Tanida, T., Hizuta, A., Nishimori, H., Tokino, T., Nakamura, Y., Bouvet, M., Roth, J. A., and Tanaka, N. Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect. Clin. Cancer Res., 5: 1015-1023, 1999.
15. DeGregori, J., Leone, G., Miron, A., Jakoi, L., and Nevins, J. R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA, 94: 7245-7250, 1997.
16. ARF links the tumor suppressors RB and p53. Nature (Lond.), 395: 124-125, 1998.
17. INK4a: a gene with a dual capacity to encode unrelated proteins that inhibit cell cycle progression. Oncogene, 12: 2041-2044, 1996.
18. Robertson, K. D., and Jones, P. A. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol. Cell. Biol., 18: 6457-6473, 1998.
19. Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., and Vogelstein, B. Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature (Lond.), 362: 857-860, 1993.
20. Kubbutat, M. H. G., Jones, S. N., and Vousden, K. H. Regulation of p53 stability by Mdm2. Nature (Lond.), 387: 299-302, 1997.
21. Zhang, Y., Xiong, Y, and Yarbrough W. G. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell, 92: 725-734, 1998.
22. ARF, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell, 92: 713-723, 1998.
23. ARF. Cell. 91: 649-659, 1997.
24. Zhang, W-W., Fang, X., Mazur, W., French, B. A., Georges, R. N., and Roth, J. A. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther., 1: 5-13, 1994.
25. Liu, T-J, Wang, M., Breau, R. L., Henderson, Y., El-Naggar, A. K., Steck, K. D., Sicard, M. W., and Clayman, G. L. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines. Cancer Gene Ther., 6: 163-171, 1999.
26. INK4a gene is frequently lost in small cell lung cancer. Cancer Res., 58: 3926-3931, 1998.
27. ARF/p16β is frequently altered in non-small cell lung cancer and correlates with p53 overexpression. Oncogene, 17: 2779-2785, 1998.
28. Athanassiou, M., Hu, Y., Jing, L., Houle, B., Zarbl, H., Mikheev, A. M. Stabilization and reactivation of the p53 tumor suppressor protein in nontumorigenic revertants of HeLa cervical cancer cells. Cell Growth Differ., 10: 729-737, 1999.
29. Harris, C. C. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutical strategies. J. Natl. Cancer Inst., 88: 1442-1455, 1996.
30. Swisher, S. G., Roth, J. A., Nemunaitis, J., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Connors, D. G., El-Naggar, A. K., Fossella, F., Glisson, B. S., Hong, W. K., Khuri, F. R., Kurie, J. M., Lee, J. J., Lee, J. S., Mack, M., Merritt, J. A., Nguyen, D. M., Nesbitt, J. C., Perez-Soler, R., Pisters, M. W., Putnam, J. B., Richli, W. R., Savin, M., Schrump, D. S., Shin, D. M., Shulkin, A., Walsh, G. L., Wait, J., Weil, D., Kimberly, A., and Waugh, A. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J. Natl. Cancer Inst., 91: 763-771, 1999.
31. Clayman, G. L., Frank, D. K., Bruso, P. A., and Goepfert, H. Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers. Clin. Cancer Res., 5: 1715-1722, 1999.
32. Barak, Y., Juven, T., Haffiner, R., and Oren, M. Mdm2 expression is induced by wild type p53 activity. EMBO J., 12: 461-468, 1993.
33. ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J., 18: 22-27, 1999.
34. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. Mdm2 promotes the rapid degradation of p53. Nature (Lond.), 387: 296-299, 1997.
35. Frank, D. K., Lui, T. J., Frederick, M. J., and Clayman, G. L. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck. Clin. Cancer Res., 4: 2265-2272, 1998.
36. Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., and Bar-Sagi, D. Nucleolar Arf sequesters Mdm2 and activates p53. Nature Cell Biol., 1: 20-26, 1999.